Neo Ivy Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,212
| Closed | -$156K | – | 671 |
|
|
2022
Q1 | $156K | Buy |
6,212
+3,847
| +163% | +$96.6K | 0.14% | 245 |
|
|
2021
Q4 | $86K | Buy |
+2,365
| New | +$86K | 0.12% | 234 |
|
|
2021
Q1 | – | Sell |
-3,340
| Closed | -$207K | – | 652 |
|
|
2020
Q4 | $207K | Buy |
3,340
+3,273
| +4,885% | +$203K | 0.23% | 155 |
|
|
2020
Q3 | $3K | Buy |
+67
| New | +$3K | ﹤0.01% | 439 |
|
|
2020
Q2 | – | Sell |
-3,647
| Closed | -$147K | – | 640 |
|
|
2020
Q1 | $147K | Buy |
+3,647
| New | +$147K | 0.24% | 170 |
|